PRE Class A Prenetics Global Limited - Class A Ordinary Share
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$20.17
· of 52w range
· above low
· to high
$11.3752w low
$27.2452w high
P/E
-5.9
EPS
$-2.68
Revenue
$22M
your badges
52W Range
$11–$27
Analyst Rating
BUY
Price Target
$36
P/E
-5.9
ROE
0.93%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
PRE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$20.17
P/E
-5.9
EPS
$-2.68
Revenue
$22M
ROE
0.93%
52W Range
$11–$27
PRE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 14, 2023 | 1-for-15 | Reverse |
| May 18, 2022 | 129-for-100 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$22M2020-12-31 → 2023-12-31
EPS$-2.682020-12-31 → 2025-12-31
Free Cash Flow$-29M2022-12-31 → 2025-12-31
Net margin·2022-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -5.95Y avg ≈-2.3 | ≈-2.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | 0.91%5Y avg ≈-30.9% | ≈-30.9% | · | · | |
| ROE | 0.93%5Y avg ≈48.4% | ≈48.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 129.45Y avg ≈34.6 | ≈34.6 | · | · | |
| Quick Ratio | 12.65Y avg ≈4.9 | ≈4.9 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Inventory Turnover | 1.15Y avg ≈8.3 | ≈8.3 | · | · | |
| Revenue / Employee | ≈$221.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-75.5%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.53 | $-0.72 | 26.3% |
| March 31, 2026 | May 14, 2026 | $-1.61 | $-1.11 | -45.4% |
| Dec. 31, 2025 | $-1.75 | $-0.35 | -404.6% | |
| Sept. 30, 2025 | $-0.53 | $-0.56 | 4.6% | |
| June 30, 2025 | $-0.94 | $-0.72 | -31.1% | |
| March 31, 2025 | $-0.80 | $-0.78 | -2.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | · | · | $22M | $13M | $13M | |
| Cost of Revenue | $490.3K | $151.8K | $5M | $10M | $9M | |
| Gross Profit | $83.0K | $92.5K | $1M | $4M | $4M | |
| R&D Expense | $5M | $9M | $9M | $6M | $6M | |
| Operating Income | $-44M | $-36M | $-38M | $-66M | $-57M | |
| Interest Expense | $59.4K | $148.5K | · | $4M | $5M | |
| Interest Income | $27M | $31M | $4M | $472.0K | $201 | |
| Pretax Income | $6M | $4M | $-43M | $-226M | $-217M | |
| Income Tax | $0 | $0 | $54.0K | $-245.0K | $3M | |
| Net Income | $6M | $4M | $-63M | $-190M | $-174M | |
| EPS (Basic) | $-2.68 | $-3.71 | $-5.58 | $-37.57 | $-178.81 | |
| EPS (Diluted) | $-2.68 | $-3.71 | $-5.58 | $-37.57 | $-178.81 | |
| Shares (Basic) | 14,052,085 | 12,494,648 | 11,246,010 | 5,069,315 | 973,134 | |
| Shares (Diluted) | 14,052,085 | 12,494,648 | 11,246,010 | 5,069,315 | · | |
| EBITDA | · | $-48M | $-52M | $-23M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $382M | $617M | $147M | $35M | |
| Receivables | $15M | $17M | $18M | $53M | $55M | |
| Inventory | $491.3K | $362.0K | $3M | $5M | $7M | |
| Current Assets | $628M | $632M | $94M | $242M | $107M | |
| PP&E (Net) | $4M | $2M | · | $13M | $13M | |
| Goodwill | $738.3K | $701.5K | $732.5K | $34M | $4M | |
| Intangibles | $780.0K | $825.0K | $13M | $15M | $24M | |
| Total Assets | $636M | $637M | $254M | $312M | $149M | |
| Current Liabilities | $5M | $13M | $39M | $57M | $59M | |
| Total Liabilities | $7M | $13M | $44M | $69M | $549M | |
| Stockholders' Equity | $630M | $624M | $620M | $237M | $-401M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-26M | $-17M | $-14M | $15M | $13M | |
| CapEx | $3M | $606.3K | $345.0K | $5M | $9M | |
| Investing Cash Flow | $-290M | $-217M | $-83M | $-46M | $-22M | |
| Financing Cash Flow | $-5M | $-1M | $-5M | $143M | $29M | |
| Free Cash Flow | $-29M | $-30M | $-14M | $10M | · | |
| Levered FCF | $-29M | · | · | $5M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | 40.6% | 47.7% | · | |
| Operating Margin | · | · | -238.7% | -8.5% | · | |
| Net Margin | · | · | -288.5% | -69.1% | · | |
| Pretax Margin | · | · | -260.6% | -66.5% | · | |
| EBITDA Margin | · | · | -238.7% | -8.5% | · | |
| ROA | 0.91% | -19.8% | -22.1% | -82.7% | · | |
| ROE | 0.93% | -11.7% | -28.3% | 232.6% | · | |
| ROIC | · | -24.4% | -25.0% | -10.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 129.4 | 2.4 | 2.4 | 4.2 | · | |
| Quick Ratio | 12.6 | 1.9 | 1.6 | 3.5 | · | |
| Interest Coverage | · | · | · | -5.6 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.1 | 1.2 | · | |
| Inventory Turnover | 1.1 | 3.1 | 3.4 | 25.4 | · | |
| Receivables Turnover | · | · | 0.6 | 5.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-2.31 | · | · | · | |
| EPS (TTM) | $-2.68 | $-3.71 | $-5.58 | $-37.57 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | · | · | $22M | $13M | · | |
| Net Income TTM | $6M | $4M | $-63M | $-190M | · | |
| P/E | -5.9 | -1.6 | -1.1 | -0.8 | · | |
| Earnings Yield | -17.0% | -64.0% | -94.4% | -125.2% | · |
Per Share
| Metric | Trend | Q4 2025 | Q4 2024 | Q4 2022 |
|---|---|---|---|---|
| EPS (TTM) | $-2.68 | $-3.71 | · |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q4 2024 | Q4 2022 |
|---|---|---|---|---|
| Net Income TTM | $6M | $4M | · | |
| P/E | -5.9 | -1.6 | · | |
| Earnings Yield | -17.0% | -64.0% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | $22M | $13M | $13M |
| Gross Margin % | · | · | 40.6% | 47.7% | · |
| Operating Margin % | · | · | -238.7% | -8.5% | · |
| Net Income | $6M | $4M | $-63M | $-190M | $-174M |
| Diluted EPS | $-2.68 | $-3.71 | $-5.58 | $-37.57 | $-178.81 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 129.4 | 2.4 | 2.4 | 4.2 | · |
| Quick Ratio | 12.6 | 1.9 | 1.6 | 3.5 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-29M | $-30M | $-14M | $10M | · |
Institutional owners (13F) 27 filers · $23.9M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
27
Value held
$23.9M
New positions
5
Exited positions
13
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-8 vs prior Q) | 13 (+1 vs prior Q) | 11 (+1 vs prior Q) | 7 (-1 vs prior Q) | -766K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Prospect Capital Advisors, LLC | $4,508,496 | 235,800 | 18.88% | Shares |
| JANE STREET GROUP, LLC | $4,303,778 | 225,093 | 18.02% | Shares |
| GOLDMAN SACHS GROUP INC | $3,226,175 | 168,733 | 13.51% | Shares |
| MILLENNIUM MANAGEMENT LLC | $2,410,764 | 126,086 | 10.10% | Shares |
| Tenzing Global Management, LLC | $2,390,000 | 125,000 | 10.01% | Shares |
| MARSHALL WACE, LLP | $904,892 | 47,327 | 3.79% | Shares |
| NOMURA HOLDINGS INC | $804,971 | 42,101 | 3.37% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $728,969 | 38,126 | 3.05% | Shares |
| UBS Group AG | $708,205 | 37,040 | 2.97% | Shares |
| XTX Topco Ltd | $582,873 | 30,485 | 2.44% | Shares |
| STEVENS CAPITAL PARTNERS | $538,171 | 28,147 | 2.25% | Shares |
| Qube Research & Technologies Ltd | $455,247 | 23,810 | 1.91% | Shares |
| MORGAN STANLEY | $448,231 | 23,443 | 1.88% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $353,720 | 18,500 | 1.48% | Call option |
| CITADEL ADVISORS LLC | $309,495 | 16,187 | 1.30% | Shares |
| CITADEL ADVISORS LLC | $265,768 | 13,900 | 1.11% | Call option |
| Integrated Quantitative Investments LLC | $260,070 | 13,602 | 1.09% | Shares |
| EntryPoint Capital, LLC | $230,549 | 12,058 | 0.97% | Shares |
| WELLS FARGO & COMPANY/MN | $191,200 | 10,000 | 0.80% | Shares |
| Operose Advisors LLC | $129,060 | 6,750 | 0.54% | Shares |
| State of Wyoming | $106,422 | 5,566 | 0.45% | Shares |
| SIMPLEX TRADING, LLC | $14,779 | 773 | 0.06% | Shares |
| ROYAL BANK OF CANADA | $6,000 | 321 | 0.03% | Shares |
| CoreCap Advisors, LLC | $478 | 25 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $172 | 9 | 0.00% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $19 | 1 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $19 | 1 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Lo Yuk Ming Dennis (2) | Aug. 7, 2023 | · | Initial filing | Board campaign | SEC |
| Da Yeung Limited (2), Yeung Danny Sheng Wu (2) ×2 filings | July 25, 2023 | · | Initial filing | · | SEC |
| For Excelsiors Limited (2), Tzang Chi Hung Lawrence (2) | March 27, 2023 | · | Initial filing | Passive investment | SEC |
| Da Yeung Limited, Yeung Danny Sheng Wu | May 31, 2022 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 6 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VRP · Invesco Exchange-Traded Fund Trust … | 0.16% | 5,148,000 | Oct. 2, 2026 | Daily |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.11% | 3,402,000 | Oct. 2, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 14, 2026 | Daily |
PRE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$36.00
+78.5%
1 12.5%
Strong Buy
6 75.0%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-10-01Mean target $35.86 +77.8%
← Below all targets
Current price $20.17
Low$30.00
Mean$35.86
High$40.00
Latest News Recent headlines mentioning this company
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth
Yahoo Finance · 3 months, 1 week ago
Prenetics Global Appoints Brian Rosin As US CFO Of IM8
Nasdaq · 4 months, 2 weeks ago
AXIS Capital Holdings' SERIES E PREFERRED Shares Crosses Above 7% Yield Territory
Nasdaq · 6 months ago
Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference
Yahoo Finance · 6 months, 1 week ago
Global Net Lease's Series C Preferred Stock Yield Pushes Past 8%
Nasdaq · 6 months, 2 weeks ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Jul 30, 2026